J Korean Soc Radiol.  2024 Mar;85(2):394-408. 10.3348/jksr.2023.0011.

Predictions of PD-L1 Expression Based on CT Imaging Features in Lung Squamous Cell Carcinoma

Affiliations
  • 1Department of Radiology, Veterans Health Service Medical Center, Seoul, Korea
  • 2Veterans Medical Research Institute, Veterans Health Service Medical Center, Seoul, Korea
  • 3Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
  • 4Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

Abstract

Purpose
To develop models to predict programmed death ligand 1 (PD-L1) expression in pulmonary squamous cell carcinoma (SCC) using CT.
Materials and Methods
A total of 97 patients diagnosed with SCC who underwent PD-L1 expression assay were included in this study. We performed a CT analysis of the tumors using pretreatment CT images. Multiple logistic regression models were constructed to predict PD-L1 positivity in the total patient group and in the 40 advanced-stage (≥ stage IIIB) patients. The area under the receiver operating characteristic curve (AUC) was calculated for each model.
Results
For the total patient group, the AUC of the ‘total significant features model’ (tumor stage, tumor size, pleural nodularity, and lung metastasis) was 0.652, and that of the ‘selected feature model’ (pleural nodularity) was 0.556. For advanced-stage patients, the AUC of the ‘selected feature model’ (tumor size, pleural nodularity, pulmonary oligometastases, and absence of interstitial lung disease) was 0.897. Among these factors, pleural nodularity and pulmonary oligometastases had the highest odds ratios (8.78 and 16.35, respectively).
Conclusion
Our model could predict PD-L1 expression in patients with lung SCC, and pleural nodularity and pulmonary oligometastases were notable predictive CT features of PD-L1.

Keyword

Lung Squamous Cell Carcinoma; Immunotherapy; Programmed Death Ligand 1; Computed Tomography
Full Text Links
  • JKSR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr